Sinapultide structure
|
Common Name | Sinapultide | ||
|---|---|---|---|---|
| CAS Number | 138531-07-4 | Molecular Weight | 2469.399 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 2047.1±65.0 °C at 760 mmHg | |
| Molecular Formula | C126H238N26O22 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 1191.9±34.3 °C | |
Use of SinapultideSinapultide is a 21-amino-acid peptide that mimics the action of human surfactant protein-B (SP-B). Sinapultide can be used for synthetic phospholipids surfactants improvement[1]. |
| Name | sinapultide |
|---|---|
| Synonym | More Synonyms |
| Description | Sinapultide is a 21-amino-acid peptide that mimics the action of human surfactant protein-B (SP-B). Sinapultide can be used for synthetic phospholipids surfactants improvement[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Sinapultide microbubble preparation (2 μg/mL, 5 μg/mL; 24 h) combined with ultrasound (0.5 MHz, 40 s) could promote the function recovery of injured AT II cells effectively via affecting TNF-α and IL-6 levels[2]. |
| In Vivo | Sinapultide-loaded microbubbles (MBs) (0.1 mg; nasal delivery; collected at 3, 6, 12 and 24 hours after LPS) improves pulmonary edema in lung injury and increases lung W/D weight in LPS-induced ALI mice[2]. |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 2047.1±65.0 °C at 760 mmHg |
| Molecular Formula | C126H238N26O22 |
| Molecular Weight | 2469.399 |
| Flash Point | 1191.9±34.3 °C |
| Exact Mass | 2467.830322 |
| LogP | 14.95 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.514 |
| L-Lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysine |
| SP-B |
| L-Lysine, L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl- |
| sinapultide |